Cita APA (7a ed.)

Y, L., JN, C., J, C., Z, T., M, P., & S, Z. (2019). Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment. Dove Medical Press.

Cita Chicago Style (17a ed.)

Y, Li, Connarn JN, Chen J, Tong Z, Palmisano M, y Zhou S. Modeling and Simulation of the Endogenous CYP3A Induction Marker 4β-hydroxycholesterol During Enasidenib Treatment. Dove Medical Press, 2019.

Cita MLA (8a ed.)

Y, Li, et al. Modeling and Simulation of the Endogenous CYP3A Induction Marker 4β-hydroxycholesterol During Enasidenib Treatment. Dove Medical Press, 2019.